Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study.
Journal: Clinical parkinsonism & related disorders
Published: February 23, 2026
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 23, 2023
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up.
Journal: Journal of Parkinson's disease
Published: August 14, 2022
24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations.
Journal: CNS drugs
Published: December 05, 2020
Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysis.
Journal: Parkinsonism & related disorders
Published: September 25, 2020
Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.
Journal: Degenerative neurological and neuromuscular disease
Published: September 04, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026